Xeris Biopharma Holdings, Inc.

NASDAQ:XERS

3.22 (USD) • At close November 4, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q3
Omzet 48.06540.63844.3948.3238.00833.19638.00829.72525.30622.07321.42911.0358.9068.0517.0899.4482.0271.7881.8640.3230.320.2480.8010.5820.8190.2630.4670.170.5650.354
Kosten van de omzet 10.58.68210.2818.2017.5555.3197.5555.264.816.2734.8893.223.3831.8263.4072.8321.2991.791.6030.010.02300.042000.042000.0040
Brutowinst 37.56531.95634.10940.11930.45327.87730.45324.46520.49615.816.547.8155.5236.2253.6826.6160.728-0.0020.2610.3130.2970.2480.7590.5820.8190.2210.4670.170.5610.354
Brutowinstmarge 0.7820.7860.7680.830.8010.840.8010.8230.810.7160.7720.7080.620.7730.5190.70.359-0.0010.140.9690.92810.948110.84110.9931
Onderzoek- en ontwikkelingskosten 5.7597.8216.3825.0346.0874.8386.0876.0433.7186.2510.0825.6635.3834.0325.113.8765.2896.64612.4215.51819.33313.16712.3910.8758.6778.7126.5785.7254.2013.662
Algemene en administratieve kosten 0000000000000017.998017.64421.60620.64214.87715.02412.5188.7254.654.4993.2393.0982.0171.5591.341
Verkoop- en marketingkosten 000000000000000000000000000000
Verkoop-, algemene en administratieve kosten 39.99338.3837.56837.28737.63533.60537.63534.49132.98435.91354.17926.53525.92719.07717.99816.48417.64421.60620.64214.87715.02412.5188.7254.654.4993.2393.0982.0171.5591.341
Overige kosten 2.71015.709-7.614-4.538-3.557-4.538-3.392.712.711-2.519-0.025000000000000000000
Bedrijfskosten 45.75246.20143.9542.32146.43241.15446.43243.24539.41244.87464.81132.17331.3122.96523.02520.3622.93328.25233.06230.39534.35725.68521.11515.52513.17611.9519.6767.7425.765.003
Bedrijfsresultaat -8.187-14.245-9.841-4.913-15.979-13.277-15.979-18.78-18.916-29.074-48.271-24.358-25.787-16.74-19.343-13.744-22.205-28.254-32.801-30.082-34.06-25.437-20.314-14.943-12.357-11.73-9.209-7.572-5.199-4.649
Bedrijfsresultaat ratio -0.17-0.351-0.222-0.102-0.42-0.4-0.42-0.632-0.747-1.317-2.253-2.207-2.895-2.079-2.729-1.455-10.955-15.802-17.597-93.133-106.438-102.569-25.361-25.675-15.088-44.601-19.719-44.541-9.202-13.133
Totaal overige inkomsten en kosten netto -6.069-4.428-3.785-7.614-4.538-3.557-4.5380.127-7.608-5.048-2.5190.081-0.010.020.055-0.16-0.0390.1350.1520.096-0.1080.5520.1330.451-0.306-0.082-0.0150.045-0.0320
Inkomen voor belasting -14.256-18.673-13.626-12.527-20.517-16.834-20.517-22.17-26.524-34.122-50.79-26.009-27.515-18.411-21.857-16-24.209-29.184-33.54-32.836-34.385-25.277-20.419-14.767-12.987-11.907-9.146-7.527-5.232-4.649
Inkomen voor belasting ratio -0.297-0.459-0.307-0.259-0.54-0.507-0.54-0.746-1.048-1.546-2.37-2.357-3.089-2.287-3.083-1.693-11.943-16.322-17.994-101.659-107.453-101.923-25.492-25.373-15.857-45.274-19.585-44.276-9.26-13.133
Belastingkosten 0.7490.307-0.2360.338-0.6752.751-0.675-0.339-0.339-0.4081.7961.7981.7951.7914.1451.945-0.111.179-0.4583.5071.0621.0630.8810.7370.4840.19100.0450.0010
Nettowinst -15.005-18.98-13.39-12.189-19.842-16.834-19.842-21.831-26.185-33.714-50.79-26.009-27.515-18.411-21.857-16-24.099-29.184-33.082-32.836-34.385-25.277-20.419-14.767-12.987-11.907-9.146-7.527-5.232-4.649
Nettowinstmarge -0.312-0.467-0.302-0.252-0.522-0.507-0.522-0.734-1.035-1.527-2.37-2.357-3.089-2.287-3.083-1.693-11.889-16.322-17.748-101.659-107.453-101.923-25.492-25.373-15.857-45.274-19.585-44.276-9.26-13.133
WPA (Winst Per Aandeel) -0.1-0.14-0.097-0.088-0.14-0.12-0.15-0.16-0.19-0.25-0.42-0.39-0.41-0.3-0.41-0.35-0.63-0.89-1.23-1.22-1.28-1.07-0.98-0.71-3.07-5.49-4.43-3.72-2.59-2.29
Verwaterde WPA -0.1-0.14-0.097-0.088-0.14-0.12-0.15-0.16-0.19-0.25-0.42-0.39-0.41-0.3-0.41-0.35-0.63-0.89-1.23-1.22-1.28-1.07-0.98-0.71-3.07-5.49-4.43-3.72-2.59-2.29
EBITDA -5.033-11.031-6.582-4.913-13.269-10.566-13.269-15.237-15.659-25.974-47.721-23.969-25.39-16.303-17.321-13.512-21.61-27.82-32.161-29.086-32.99-24.632-19.497-14.476-12.119-11.571-9.077-7.475-5.166-4.611
EBITDA ratio -0.105-0.271-0.148-0.102-0.349-0.318-0.349-0.513-0.619-1.177-2.227-2.172-2.851-2.025-2.443-1.43-10.661-15.559-17.254-90.05-103.094-99.323-24.341-24.873-14.797-43.996-19.437-43.971-9.143-13.025